Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
DecisionDx-SCC might assist medical doctors extra precisely information remedy in high-risk cutaneous squamous cell carcinoma, the second most typical type of pores and...
A survivor shares how household, care groups and mentoring others helped her face stage 3C ovarian most cancers and reclaim independence with hope.Mary...
